333 related articles for article (PubMed ID: 11072868)
21. Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase.
Cerri A; Gobbini M
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):289-95. PubMed ID: 14567542
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of erythrocyte Na,K-ATPase activity during anticipatory hypoventilation in micropigs.
Fedorova OV; French AW; Anderson DE
Am J Hypertens; 1996 Nov; 9(11):1126-31. PubMed ID: 8931839
[TBL] [Abstract][Full Text] [Related]
24. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis).
Gupta RS; Chopra A; Stetsko DK
J Cell Physiol; 1986 May; 127(2):197-206. PubMed ID: 3009493
[TBL] [Abstract][Full Text] [Related]
25. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
26. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
27. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
28. Tissue localization of active Na,K-ATPase isoenzymes by determination of their profile of inhibition with ouabain, digoxin, digitoxigenin and LND 796, a new aminosteroid cardiotonic.
Maixent JM; Fénard S; Kawamoto RM
J Recept Res; 1991; 11(1-4):687-98. PubMed ID: 1653353
[TBL] [Abstract][Full Text] [Related]
29. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate.
Tao QF; Hollenberg NK; Price DA; Graves SW
Hypertension; 1997 Mar; 29(3):815-21. PubMed ID: 9052901
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
Ozaki H; Nagase H; Urakawa N
J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
[TBL] [Abstract][Full Text] [Related]
31. Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase.
Katz A; Lifshitz Y; Bab-Dinitz E; Kapri-Pardes E; Goldshleger R; Tal DM; Karlish SJ
J Biol Chem; 2010 Jun; 285(25):19582-92. PubMed ID: 20388710
[TBL] [Abstract][Full Text] [Related]
32. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
Tao QF; Hollenberg NK; Graves SW
Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
[TBL] [Abstract][Full Text] [Related]
33. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
35. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
[TBL] [Abstract][Full Text] [Related]
36. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
Balzan S; Montali U; Ghione S
Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
[No Abstract] [Full Text] [Related]
37. Sugar moiety of cardiac glycosides is essential for the inhibitory action on the palytoxin-induced K+ release from red blood cells.
Ozaki H; Nagase H; Urakawa N
FEBS Lett; 1984 Jul; 173(1):196-8. PubMed ID: 6146536
[TBL] [Abstract][Full Text] [Related]
38. Influence of extracellular K+ concentration on the time-course of Na+/K+-ATPase inhibition by cardiac glycosides with fast and low binding kinetics.
Gleitz J; Peters M
Eur J Pharmacol; 1997 Sep; 335(1):89-97. PubMed ID: 9371549
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
[TBL] [Abstract][Full Text] [Related]
40. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
Brown L; Erdmann E; Thomas R
Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
